about
Burkitt's lymphoma: new insights into molecular pathogenesisPathologic aspects of AIDS malignancies.Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus.Immunoglobulin gene rearrangement analysis in composite hodgkin disease and large B-cell lymphoma: evidence for receptor revision of immunoglobulin heavy chain variable region genes in Hodgkin-Reed-Sternberg cells?Lacunar and reed-sternberg-like cells in follicular lymphomas are clonally related to the centrocytic and centroblastic cells as demonstrated by laser capture microdissection.CD34+ cord blood cell-transplanted Rag2-/- gamma(c)-/- mice as a model for Epstein-Barr virus infectionDouble-staining chromogenic in situ hybridization as a useful alternative to split-signal fluorescence in situ hybridization in lymphoma diagnostics.Alteration of microRNAs regulated by c-Myc in Burkitt lymphomaThe pathologist's view point. Part I--indolent lymphomas.The pathologist's view point. Part II --aggressive lymphomas.Lymphomas in sub-Saharan Africa--what can we learn and how can we help in improving diagnosis, managing patients and fostering translational research?The alteration of lipid metabolism in Burkitt lymphoma identifies a novel marker: adipophilinHodgkin's lymphoma: the pathologist's viewpointUpdate on extranodal lymphomas. Conclusions of the Workshop held by the EAHP and the SH in Thessaloniki, Greece.A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma.p53 mutation in breast cancer. Correlation with cell kinetics and cell of origin.The tumor virus landscape of AIDS-related lymphomasThe presence of Epstein-Barr virus significantly impacts the transcriptional profile in immunodeficiency-associated Burkitt lymphoma.A review of the pattern of AIDS defining, HIV associated neoplasms and premalignant lesions diagnosed from 2000-2011 at Kenyatta National Hospital, KenyaDistinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma.Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypes.Aggressive B-cell lymphomas: a review based on the workshop of the XI Meeting of the European Association for Haematopathology.Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation.Treatment of Burkitt lymphoma in equatorial Africa using a simple three-drug combination followed by a salvage regimen for patients with persistent or recurrent diseaseEpstein-Barr nuclear antigen 1 induces expression of the cellular microRNA hsa-miR-127 and impairing B-cell differentiation in EBV-infected memory B cells. New insights into the pathogenesis of Burkitt lymphomaThe surgical pathology laboratory in Mwanza, Tanzania: a survey on the reproducibility of diagnoses after the first years of autonomous activity.Targeted genomic sequencing of pediatric Burkitt lymphoma identifies recurrent alterations in antiapoptotic and chromatin-remodeling genes.Clonality Analysis of Immunoglobulin Gene Rearrangement by Next-Generation Sequencing in Endemic Burkitt Lymphoma Suggests Antigen Drive Activation of BCR as Opposed to Sporadic Burkitt Lymphoma.HIV-1 Tat mimetic of VEGF correlates with increased microvessels density in AIDS-related diffuse large B-cell and Burkitt lymphomas.Translocation detection in lymphoma diagnosis by split-signal FISH: a standardised approach.Role of EBV in microRNA dysregulation in Burkitt lymphoma.Correlation of EGFR, pEGFR and p16INK4 expressions and high risk HPV infection in HIV/AIDS-related squamous cell carcinoma of conjunctiva.The Epstein Barr-encoded BART-6-3p microRNA affects regulation of cell growth and immuno response in Burkitt lymphomaGeographic variation and environmental conditions as cofactors in Chlamydia psittaci association with ocular adnexal lymphomas: a comparison between Italian and African samples.Infectious agents and lymphoma.Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomasExpression of RB2/p130 tumor-suppressor gene in AIDS-related non-Hodgkin's lymphomas: implications for disease pathogenesis.Unveiling Another Missing Piece in EBV-Driven Lymphomagenesis: EBV-Encoded MicroRNAs Expression in EBER-Negative Burkitt Lymphoma Cases.Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes.B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression.
P50
Q24672911-5F5AC60C-CF49-44A1-8112-A6662AF917B0Q30336144-F5686972-81EE-4569-A798-49C4AA0E6BFDQ30610963-9AF4879A-5DFE-46BF-8D7A-58E1E7E77B39Q30815651-0A5A1911-E758-4CE5-9827-745E2AFD8207Q31126997-C7B20F65-CEB0-43E4-912D-EB4643B6F7C7Q33374980-57C2DA03-D650-4D19-B693-D4FB6AC5DB44Q33632235-40F0A874-227E-4969-B626-AA6BFE446A29Q33712780-D9949D86-7E4A-448E-B8C3-B1F69DA0BE42Q34103198-E92C287C-D1F4-4FC7-9C8E-49E31BB5C888Q34103203-F44E9A2A-D9BD-48AA-893F-17915759F120Q34391704-66E32403-6867-4CDC-B160-6C9DC32D36C8Q34406580-36E2091A-B98D-40B7-8651-643FFC0741C0Q34564836-E691C3BC-0A82-49BC-A5DE-0775A2182A21Q34569256-0C5659C9-B528-4D62-8131-9942C77FB222Q35001620-C9E607E4-159F-4E04-95AC-5F949C5CDC59Q35586221-D401A2F9-9B9A-49F9-B8BD-972B684468BFQ35607311-05B5F6E3-E46B-4497-B5CD-A2A8162A00A2Q35711180-6C503113-44DD-4B04-9420-A2C5B0C80BBDQ35754995-63D312DC-5393-49C5-B7B7-DDE3B2FD7177Q35808018-4DF59B34-0909-4ABF-AD3C-6A3732228991Q35809785-E550CD8E-1818-440D-9B2D-37F543897D78Q36048644-81A94CE0-3F54-4722-9EBA-39B8FFBA2836Q36143915-8D2A278A-FDAF-49BC-B81D-0A88BD5F67D4Q36201443-F5ACDA74-F017-4A1D-B57A-D7AAA40B2F26Q36204326-68306E09-6B3D-43FC-8FEB-81D9D6C386ACQ36262034-EADF654A-7A4E-4507-822A-409650DD623BQ36509645-11037A50-2634-4E68-88B9-0E680532C88DQ36651583-767DAF06-7420-4DB8-8EE4-4E06A7DA4384Q37266075-85BC396C-10DA-422D-A5DB-DEB5110DE846Q37269015-1AFE9846-1AA6-4ACA-8428-8806E844A05DQ37556794-8ADFF287-E62B-4764-99EE-7F1510B3E92DQ37717281-1672FF80-1C66-403A-B9EB-4C0727B3553AQ37733947-36691DC6-7BDE-4EA5-BE0F-9A6BCCB226EFQ37854356-11D9D5C6-BB0C-43FE-A0CA-7094464495CAQ37917744-8BEC68E9-6ECB-4F27-8315-EDA134B3A8DAQ38296711-C7C6F043-AE52-436F-AFF7-6B52D6B55970Q38363528-436EF03E-5D73-457E-BCA3-AF272C039F6CQ38904899-FD8EFAEA-B9B8-4B77-B3E0-8508E8058BD4Q39606098-2F25B939-6FAC-4DAB-B420-30C3DDDA1202Q39837455-E19F2DEF-E911-4972-A055-6CA5F3D2F095
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Lorenzo Leoncini
@ast
Lorenzo Leoncini
@en
Lorenzo Leoncini
@es
Lorenzo Leoncini
@nl
Lorenzo Leoncini
@sl
type
label
Lorenzo Leoncini
@ast
Lorenzo Leoncini
@en
Lorenzo Leoncini
@es
Lorenzo Leoncini
@nl
Lorenzo Leoncini
@sl
prefLabel
Lorenzo Leoncini
@ast
Lorenzo Leoncini
@en
Lorenzo Leoncini
@es
Lorenzo Leoncini
@nl
Lorenzo Leoncini
@sl
P106
P1153
7005774545
P21
P31
P496
0000-0002-7457-300X